Wall Street Associates’s Enanta Pharmaceuticals ENTA Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	$342K	Hold	10,200	–	–	0.23%	156
2016 Q3	$271K	Hold	10,200	–	–	0.09%	201
2016 Q2	$225K	Hold	10,200	–	–	0.09%	207
2016 Q1	$300K	Hold	10,200	–	–	0.12%	183
2015 Q4	$337K	Hold	10,200	–	–	0.09%	262
2015 Q3	$369K	Sell	10,200 -136,100	-93%	-$5.84M	0.07%	253
2015 Q2	$6.58M	Sell	146,300 -5,500	-4%	-$214K	0.62%	56
2015 Q1	$4.65M	Sell	151,800 -6,600	-4%	-$257K	0.44%	82
2014 Q4	$8.05M	Sell	158,400 -700	-0.4%	-$31.3K	0.77%	36
2014 Q3	$6.3M	Sell	159,100 -60,100	-27%	-$2.4M	0.65%	50
2014 Q2	$9.44M	Buy	219,200 +2,600	+1%	+$99.2K	0.81%	29
2014 Q1	$8.66M	Sell	216,600 -53,800	-20%	-$1.95M	0.71%	43
2013 Q4	$7.38M	Buy	270,400 +15,500	+6%	+$376K	0.6%	55
2013 Q3	$5.84M	Sell	254,900 -7,900	-3%	-$151K	0.54%	60
2013 Q2	$4.65M	Buy	+262,800	New	+$5.12M	0.47%	73